University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane receptors called G protein-coupled receptors (GPCRs). GPCRs are indispensable for ...
The failure of many potential candidates during clinical trials significantly impacts the cost of drug development. Computational drug design has the means to lower these costs by allowing not only ...
CAMBRIDGE, England--(BUSINESS WIRE)--DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results